Tectonic Therapeutic | AVRO - Ingresos Por Ventas

Precio De Mercado
28.54
Cambio Diario
0.10 0.35%
Mensual
-8.11%
Anual
35.32%
Q2 Expectativa
27.93




Ventas Cambio Fecha
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
MacroGenics USD 41.23M 31.61M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pfizer USD 17.58B 880M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Takeda JPY 1.19T 80B 2025-12
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09